OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pancreatic neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]
Beata Kos‐Kudła, Violetta Rosiek, Małgorzata Borowska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 491-548
Open Access | Times Cited: 18
Beata Kos‐Kudła, Violetta Rosiek, Małgorzata Borowska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 491-548
Open Access | Times Cited: 18
Showing 18 citing articles:
European Neuroendocrine Tumour Society (ENETS ) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Beata Kos‐Kudła, Justo P. Castaño, Timm Denecke, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 12
Open Access | Times Cited: 94
Beata Kos‐Kudła, Justo P. Castaño, Timm Denecke, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 12
Open Access | Times Cited: 94
Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors
Francesco Panzuto, Angela Lamarca, Nicola Fazio
Cancer Treatment Reviews (2024) Vol. 129, pp. 102803-102803
Open Access | Times Cited: 7
Francesco Panzuto, Angela Lamarca, Nicola Fazio
Cancer Treatment Reviews (2024) Vol. 129, pp. 102803-102803
Open Access | Times Cited: 7
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5542-5542
Open Access | Times Cited: 21
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5542-5542
Open Access | Times Cited: 21
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
Erfan Taherifard, Muhammad Bakhtiar, Mahnoor Mahnoor, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Erfan Taherifard, Muhammad Bakhtiar, Mahnoor Mahnoor, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review
A. Namysł-Kaletka, Jerzy Wydmański, Iwona Dębosz-Suwińska, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 4123-4132
Open Access | Times Cited: 1
A. Namysł-Kaletka, Jerzy Wydmański, Iwona Dębosz-Suwińska, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 4123-4132
Open Access | Times Cited: 1
A calcitonin secreting pancreatic neuroendocrine tumor with liver metastasis and hepatic vein thrombosis: a case report
Nina Piłka, Mateusz Drabczyk
Quality in Sport (2024) Vol. 35, pp. 55771-55771
Open Access | Times Cited: 1
Nina Piłka, Mateusz Drabczyk
Quality in Sport (2024) Vol. 35, pp. 55771-55771
Open Access | Times Cited: 1
Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome
Violetta Rosiek, Agnes Bocian, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 8, pp. 2348-2348
Open Access | Times Cited: 3
Violetta Rosiek, Agnes Bocian, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 8, pp. 2348-2348
Open Access | Times Cited: 3
Management of small, asymptomatic, non-functioning pancreatic neuroendocrine tumours: follow-up, ablation, or surgery?
Krzysztof Dąbkowski, Teresa Starzyńska
Endokrynologia Polska (2022) Vol. 74, Iss. 1, pp. 25-30
Open Access | Times Cited: 5
Krzysztof Dąbkowski, Teresa Starzyńska
Endokrynologia Polska (2022) Vol. 74, Iss. 1, pp. 25-30
Open Access | Times Cited: 5
Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4687-4687
Open Access | Times Cited: 2
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4687-4687
Open Access | Times Cited: 2
The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
Monika Wójcik-Giertuga, Anna Malczewska, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 22, pp. 5477-5477
Open Access | Times Cited: 2
Monika Wójcik-Giertuga, Anna Malczewska, Beata Kos‐Kudła
Cancers (2023) Vol. 15, Iss. 22, pp. 5477-5477
Open Access | Times Cited: 2
Gastroduodenal neuroendocrine neoplasms including gastrinoma — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma — uaktualnione zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Grażyna Rydzewska, Janusz Strzelczyk, Tomasz Bednarczuk, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 455-490
Open Access | Times Cited: 3
Grażyna Rydzewska, Janusz Strzelczyk, Tomasz Bednarczuk, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 455-490
Open Access | Times Cited: 3
Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, et al.
(2023)
Open Access | Times Cited: 1
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, et al.
(2023)
Open Access | Times Cited: 1
Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
Agnes Bocian, Anna Malczewska, Violetta Rosiek, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3517-3517
Open Access | Times Cited: 1
Agnes Bocian, Anna Malczewska, Violetta Rosiek, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3517-3517
Open Access | Times Cited: 1
Abordaje del insulinoma: revisión actualizada de la literatura
Kevin Guillermo Castro Gomez, Jeiver Aldúbar Contreras Romero, Daniela Valentina Afanador Jaimes, et al.
Revista Colombiana de Endocrinología Diabetes & Metabolismo (2024) Vol. 11, Iss. 1
Open Access
Kevin Guillermo Castro Gomez, Jeiver Aldúbar Contreras Romero, Daniela Valentina Afanador Jaimes, et al.
Revista Colombiana de Endocrinología Diabetes & Metabolismo (2024) Vol. 11, Iss. 1
Open Access
Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection
Helena Olearska, Anna Sowa‐Staszczak, Karolina Morawiec-Sławek, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 1, pp. 102-108
Open Access
Helena Olearska, Anna Sowa‐Staszczak, Karolina Morawiec-Sławek, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 1, pp. 102-108
Open Access
Down-regulation of TAK1 inhibits migration and invasion of p-NENs by regulating JNK signaling pathway through interaction with PDZD2
Xiaoyu Yang, Jianwei Qiu
Research Square (Research Square) (2024)
Open Access
Xiaoyu Yang, Jianwei Qiu
Research Square (Research Square) (2024)
Open Access
Novel radiopharmaceuticals in endocrinology: a comprehensive review
Mateusz Pocięgiel, Tomasz Saniewski, Karol Wrzosek, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 617-629
Open Access
Mateusz Pocięgiel, Tomasz Saniewski, Karol Wrzosek, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 617-629
Open Access
The Clinical Applications of Selected Circulating Tumor Biomarkers in Patients with Pancreatic Neuroendocrine Tumors/Neoplasms
Violetta Rosiek, Anna Zemczak, Magdalena Londzin-Olesik, et al.
(2023)
Open Access
Violetta Rosiek, Anna Zemczak, Magdalena Londzin-Olesik, et al.
(2023)
Open Access
